Page last updated: 2024-08-22

lutetium and Neoplasms

lutetium has been researched along with Neoplasms in 52 studies

Research

Studies (52)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.92)18.7374
1990's2 (3.85)18.2507
2000's16 (30.77)29.6817
2010's24 (46.15)24.3611
2020's9 (17.31)2.80

Authors

AuthorsStudies
Garnuszek, P; Karczmarczyk, U; Maurin, M; Sawicka, A; Wojdowska, W1
Abedi, SM; Hosseinimehr, SJ; Khorramimoghaddam, A; Molavipordanjani, S; Mousavi, T; Talebpour Amiri, F1
Alcocer-Ávila, M; Champion, C; Hindié, E; Larouze, A; Morgat, C1
Al-Baddai, S; Chen, S; Götz, TI; Kuwert, T; Lang, EW; Schmidkonz, C1
Behe, M; Grob, NM; Mindt, TL; Schibli, R; Schmid, S1
Belli, ML; Canali, E; Caroli, P; Celli, M; Cremonesi, M; Di Iorio, V; Ferrari, M; Grassi, I; Matteucci, F; Mezzenga, E; Nicolini, S; Paganelli, G; Sansovini, M; Sarnelli, A; Severi, S; Tardelli, E1
Bernhardt, P; Cohrs, S; Fang, HY; Guzik, P; Müller, C; Schibli, R; Siwowska, K1
Bassi, G; Biancofiore, I; Cazzamalli, S; Dakhel Plaza, S; Donckele, EJ; Elsayed, A; Gloger, A; Millul, J; Mock, J; Nadal, L; Neri, D; Pellegrino, C; Samain, F; Schmidt, E; Zana, A1
Ai, X; Fu, L; Hao, P; Li, L; Wei, P; Zhang, J; Zhou, J1
Cai, W; Cheng, L; Engle, JW; Ferreira, CA; He, Q; Kutyreff, CJ; Lan, X; Ni, D; Rosenkrans, ZT; Wei, H; Yu, B; Yu, F1
Adumeau, P; Davydova, M; Zeglis, BM1
Buxbaum, S; Fink, K; Maffey-Steffan, J; Mair, C; Nilica, B; Scarpa, L; Virgolini, IJ; Warwitz, B1
Bednarz, B; Lee, D; Li, M; Schultz, MK1
Alshehri, S; Fan, W; Garrison, JC; Neeley, TR; Zhang, W1
Anderson, CJ; Berkman, CE; Choy, CJ; Geruntho, JJ; Kurland, BF; Langton-Webster, B; Latoche, JD; Laymon, CM; Ling, X; Rigatti, LH; Salamacha, N; Shen, D; Windish, HP; Wu, Y1
Chen, X; Chen, Z; Huang, M; Huang, P; Li, R; Ma, E; Tu, D; Zheng, W; Zhou, S; Zhu, H1
Díaz-Nieto, L; Ferro-Flores, G; Gómez-Oliván, L; Jiménez-Mancilla, N; Luna-Gutiérrez, M; Morales-Avila, E; Ocampo-García, B; Pedraza-López, M; Santos-Cuevas, C; Vilchis-Juárez, A1
Celler, A; Grimes, J1
Azorín-Vega, EP; Ferro-Flores, G; Ocampo-García, BE; Rojas-Calderón, EL; Zambrano-Ramírez, OD1
Yoshikawa, K1
Bandari, RP; Jiang, Z; Reynolds, TS; Smith, CJ1
Knapp, FF; Pillai, AM1
Banerjee, S; Knapp, FF; Pillai, MR1
Amato, E; Baldari, S; Italiano, A; Leotta, S1
Feron, O; Gallez, B; Lucas, S; Masereel, B; Michiels, C; Vander Borght, T1
Huang, L; Satterlee, AB; Yuan, H1
Cho, EH; Jung, SH; Lee, SY; Lim, JC1
Dayton, PA; Huang, L; Rojas, JD; Satterlee, AB1
Tweedle, MF1
Bombardieri, E; Canevari, S; Coliva, A; Figini, M; Giussani, A; Luison, E; Seregni, E; Zacchetti, A1
Banerjee, S; Chakraborty, S; Das, T; Sarma, HD; Venakatesh, M1
Grüll, H; Nicolay, K; Robillard, MS; van Duijnhoven, SM1
de Jong, M; Konijnenberg, MW1
Beran, M; Chinol, M; Eigner, S; Henke, KE; Laznicek, M; Laznickova, A; Melichar, F; Vera, DR1
Cescato, R; Fani, M; Reubi, JC; Waser, B1
Fani, M; Maecke, HR; Reubi, JC; Rivier, J; Schulz, S; Wang, X1
MAEDA, T1
Boerman, OC; Corstens, FH; Frielink, C; Goldenberg, DM; Oyen, WJ; Postema, EJ; Raemaekers, JM1
Bossuyt, A; Caveliers, V; Everaert, H; Franken, PR; Lahoutte, T; Muylle, K; Vanhove, C1
Boellaard, R; Comans, EF; Hoekstra, OS; Joshi, U; Miller, SD; Pijpers, RJ; Raijmakers, PG; Teule, GJ; van Lingen, A1
Czernin, J; Dahlbom, M; Halpern, BS; Quon, A; Ratib, O; Schiepers, C; Silverman, DH; Waldherr, C1
Boerdijk, SM; Paans, AM; Pruim, J; Willemsen, AT1
Banerjee, S; Chakraborty, S; Das, T; Kagiya, VT; Mukherjee, A; Nair, CK; Samuel, G; Sarma, HD; Venkatesh, M1
Anderson, T; Atcher, R; Nayak, T; Norenberg, J1
Auerbach, MA; Czernin, J; Dahlbom, M; Fueger, BJ; Halpern, BS; Ratib, O; Schiepers, C; Silverman, DH; Weber, WA1
Ametamey, S; Bläuenstein, P; Grünberg, J; Honer, M; Knogler, K; Maecke, HR; Novak-Hofer, I; Schubiger, PA; Zimmermann, K1
Badawi, RD; Dibos, PE; Gilbert, R; Line, BR; Lodge, MA1
Nunn, AD; Panigone, S1
Carrasquillo, JA; Chung, Y; Curt, G; Feuerstein, I; Milenic, DE; Mulligan, T; Paik, C; Perentesis, P; Reynolds, J; Schlom, J1
Bakker, WH; Bugaj, JL; de Jong, M; Erion, JL; Konijnenberg, MW; Kooij, PP; Krenning, EP; Kwekkeboom, DJ; Schmidt, MA; Srinivasan, A1

Reviews

5 review(s) available for lutetium and Neoplasms

ArticleYear
Does the Number of Bifunctional Chelators Conjugated to a mAb Affect the Biological Activity of Its Radio-Labeled Counterpart? Discussion Using the Example of mAb against CD-20 Labeled with
    Journal of medicinal chemistry, 2022, 05-12, Volume: 65, Issue:9

    Topics: Antibodies, Monoclonal; Chelating Agents; Humans; Lutetium; Neoplasms; Radioimmunotherapy; Radioisotopes; Rituximab; Tissue Distribution

2022
Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy.
    Current radiopharmaceuticals, 2016, Volume: 9, Issue:1

    Topics: Animals; Bombesin; Humans; Lutetium; Molecular Imaging; Neoplasms; Radioisotopes; Radiopharmaceuticals; Receptors, Bombesin

2016
Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.
    Chemical reviews, 2015, Apr-22, Volume: 115, Issue:8

    Topics: Animals; Humans; Lutetium; Molecular Conformation; Neoplasms; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals

2015
Preclinical animal research on therapy dosimetry with dual isotopes.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38 Suppl 1

    Topics: Animals; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Indium Radioisotopes; Lutetium; Neoplasms; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Yttrium Radioisotopes

2011
Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2006, Volume: 50, Issue:4

    Topics: Antibodies, Monoclonal; Drug Delivery Systems; Gastrin-Releasing Peptide; Humans; Lutetium; Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin

2006

Trials

4 trial(s) available for lutetium and Neoplasms

ArticleYear
Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Equipment Design; Equipment Failure Analysis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lutetium; Male; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Silicates; Sodium Iodide; Transducers; Whole-Body Counting

2004
Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:4

    Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lutetium; Male; Middle Aged; Neoplasms; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Silicates; Subtraction Technique; Tomography, X-Ray Computed

2005
Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:12

    Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Lutetium; Male; Middle Aged; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage

1995
Photodynamic therapy trial expands.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Female; Humans; Injections, Intravenous; Lighting; Lutetium; Male; Metalloporphyrins; Neoplasms; Photochemotherapy; Photosensitizing Agents; Sarcoma, Kaposi

1996

Other Studies

43 other study(ies) available for lutetium and Neoplasms

ArticleYear
The preclinical study of
    Annals of nuclear medicine, 2023, Volume: 37, Issue:7

    Topics: Animals; Cell Line, Tumor; Humans; Lutetium; Mice; Mice, Nude; Neoplasms; Radiopharmaceuticals; Tissue Distribution

2023
Membrane and Nuclear Absorbed Doses from
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:10

    Topics: Humans; Lutetium; Neoplasms; Radioisotopes; Radiopharmaceuticals

2023
A deep learning approach to radiation dose estimation.
    Physics in medicine and biology, 2020, 02-04, Volume: 65, Issue:3

    Topics: Algorithms; Deep Learning; Glutamate Carboxypeptidase II; Humans; Lutetium; Monte Carlo Method; Neoplasms; Neural Networks, Computer; Organs at Risk; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, X-Ray Computed

2020
Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions.
    Journal of medicinal chemistry, 2020, 05-14, Volume: 63, Issue:9

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Gastrins; Humans; Lutetium; Mice; Neoplasms; Peptidomimetics; Protein Binding; Radioisotopes; Radiopharmaceuticals; Receptor, Cholecystokinin B; Triazoles

2020
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.
    Journal of visualized experiments : JoVE, 2020, 04-24, Issue:158

    Topics: Adult; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Neoplasms; Prostate-Specific Antigen; Radioisotopes; Radiometry; Receptors, Peptide; Single Photon Emission Computed Tomography Computed Tomography

2020
Promising potential of [
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:4

    Topics: Animals; Cell Line, Tumor; Folic Acid; Immunotherapy; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals

2021
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 04-20, Volume: 118, Issue:16

    Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Endopeptidases; Fibroblasts; Gene Expression; Gene Expression Regulation, Neoplastic; Isotope Labeling; Ligands; Lutetium; Male; Membrane Proteins; Mice; Mice, Nude; Neoplasms; Quinolines; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays

2021
DNA-assisted upconversion nanoplatform for imaging-guided synergistic therapy and laser-switchable drug detoxification.
    Biomaterials, 2017, Volume: 136

    Topics: Animals; Antineoplastic Agents; Delayed-Action Preparations; DNA; Female; HEK293 Cells; HeLa Cells; Humans; Hyperthermia, Induced; Luminescent Agents; Lutetium; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Optical Imaging; Phototherapy; Polymers; Pyrroles; Sodium Fluoride

2017
Efficient Uptake of
    Angewandte Chemie (International ed. in English), 2018, 01-02, Volume: 57, Issue:1

    Topics: Drug Delivery Systems; Humans; Lutetium; Mitochondria; Multimodal Imaging; Nanoparticles; Neoplasms; Optical Imaging; Photochemotherapy; Polyethylene Glycols; Porphyrins; Positron-Emission Tomography; Radioisotopes; Theranostic Nanomedicine

2018
Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability.
    Bioconjugate chemistry, 2018, 04-18, Volume: 29, Issue:4

    Topics: Animals; Chelating Agents; Humans; Immunoconjugates; Lutetium; Mesylates; Mice; Mice, Nude; Neoplasms; Positron-Emission Tomography; Radioisotopes; Sulfhydryl Compounds; Zirconium

2018
Radiation exposure after
    Annals of nuclear medicine, 2018, Volume: 32, Issue:7

    Topics: Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Kidney; Lutetium; Neoplasms; Octreotide; Organometallic Compounds; Organs at Risk; Prostate-Specific Antigen; Radiometry; Radiotherapy Dosage; Salivary Glands; Single Photon Emission Computed Tomography Computed Tomography; Whole Body Imaging

2018
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Radiation research, 2018, Volume: 190, Issue:3

    Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes

2018
Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.
    European journal of medicinal chemistry, 2019, Sep-01, Volume: 177

    Topics: Animals; Cathepsins; Enzyme Inhibitors; Female; HT29 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Lutetium; Mice, SCID; Neoplasms; Peptides; Radioisotopes; Radiopharmaceuticals; Receptors, Neurotensin; Tissue Distribution

2019
Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403.
    Molecular imaging and biology, 2020, Volume: 22, Issue:2

    Topics: Animals; Antigens, Surface; Drug Screening Assays, Antitumor; Glutamate Carboxypeptidase II; Humans; Lutetium; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Radioisotopes; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Single Photon Emission Computed Tomography Computed Tomography; Tissue Distribution; Xenograft Model Antitumor Assays

2020
Lanthanide-doped LiLuF(4) upconversion nanoprobes for the detection of disease biomarkers.
    Angewandte Chemie (International ed. in English), 2014, Jan-27, Volume: 53, Issue:5

    Topics: Biomarkers; Biosensing Techniques; Cell Line, Tumor; Cell Survival; Chorionic Gonadotropin; Humans; Infrared Rays; Lanthanoid Series Elements; Lithium; Lutetium; Metal Nanoparticles; Microscopy, Confocal; Neoplasms; Tomography, X-Ray Computed

2014
Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice.
    Journal of biomedical nanotechnology, 2014, Volume: 10, Issue:3

    Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chemoradiotherapy; Gold; Lutetium; Male; Metal Nanoparticles; Mice; Mice, Nude; Molecular Targeted Therapy; Nanoconjugates; Neoplasms; Neovascularization, Pathologic; Peptides, Cyclic; Radioisotopes; Rats; Xenograft Model Antitumor Assays

2014
Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques.
    Medical physics, 2014, Volume: 41, Issue:9

    Topics: Algorithms; Computer Simulation; Female; Humans; Iodine Radioisotopes; Kidney; Liver; Lutetium; Male; Models, Biological; Monte Carlo Method; Neoplasms; Niacinamide; Octreotide; Radiation Dosage; Radiopharmaceuticals; Software; Technetium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes

2014
Tumoral fibrosis effect on the radiation absorbed dose of (177)Lu-Tyr(3)-octreotate and (177)Lu-Tyr(3)-octreotate conjugated to gold nanoparticles.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2015, Volume: 100

    Topics: Fibrosis; Gold; HeLa Cells; Humans; Lutetium; Metal Nanoparticles; Models, Biological; Monte Carlo Method; Neoplasms; Octreotide; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Theranostic Nanomedicine

2015
[C-11 imaging using LSO PET-CT].
    Nihon Hoshasen Gijutsu Gakkai zasshi, 2007, Volume: 63, Issue:3 Suppl

    Topics: Carbon Radioisotopes; Humans; Lutetium; Neoplasms; Positron-Emission Tomography; Silicates; Tomography, X-Ray Computed

2007
Editorial: Lutetium-177 Labeled Therapeutics: Emerging Importance for Cancer Treatment and Therapy of Chronic Disease.
    Current radiopharmaceuticals, 2015, Volume: 8, Issue:2

    Topics: Chronic Disease; Humans; Lutetium; Neoplasms; Nuclear Medicine; Radioisotopes

2015
A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2015, Volume: 31, Issue:5

    Topics: Capillaries; Indium Radioisotopes; Iodine Radioisotopes; Isotope Labeling; Lutetium; Monte Carlo Method; Neoplasms; Nuclear Medicine; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radium

2015
Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
    Computational and mathematical methods in medicine, 2015, Volume: 2015

    Topics: Algorithms; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Humans; Iodine Radioisotopes; Lung; Lung Neoplasms; Lutetium; Models, Statistical; Monte Carlo Method; Nanomedicine; Neoplasms; Radiation Pneumonitis; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Yttrium Radioisotopes

2015
A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Nov-10, Volume: 217

    Topics: Animals; Apoptosis; Calcium Phosphates; Cell Line, Tumor; DNA Damage; Female; Humans; Lutetium; Mice; Mice, Nude; Nanoparticles; Neoplasms; NIH 3T3 Cells; Radioisotopes; Theranostic Nanomedicine; Tomography, Emission-Computed, Single-Photon; Tumor Microenvironment

2015
An assessment tumor targeting ability of (177)Lu labeled cyclic CCK analogue peptide by binding with cholecystokinin receptor.
    Journal of pharmacological sciences, 2016, Volume: 131, Issue:3

    Topics: Animals; Cell Line, Tumor; Cholecystokinin; Heterografts; Humans; Lutetium; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Pancreatic Neoplasms; Peptides, Cyclic; Protein Binding; Radioisotopes; Radioligand Assay; Receptors, Cholecystokinin

2016
Enhancing Nanoparticle Accumulation and Retention in Desmoplastic Tumors via Vascular Disruption for Internal Radiation Therapy.
    Theranostics, 2017, Volume: 7, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Drug Therapy, Combination; Lutetium; Mice; Nanoparticles; Neoplasms; Radioisotopes; Stilbenes; Treatment Outcome

2017
Peptide-targeted diagnostics and radiotherapeutics.
    Accounts of chemical research, 2009, Jul-21, Volume: 42, Issue:7

    Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cell Line; ErbB Receptors; Gadolinium; Humans; Lutetium; Male; Molecular Sequence Data; Neoplasms; Oligopeptides; Peptides; Positron-Emission Tomography; Prostatic Neoplasms; Protein Binding; Radiopharmaceuticals; Rats; Receptors, G-Protein-Coupled; Tuftsin

2009
(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Carrier Proteins; Cell Line, Tumor; Female; Folate Receptors, GPI-Anchored; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Isotope Labeling; Lutetium; Maximum Tolerated Dose; Mice; Neoplasms; Radioimmunotherapy; Radioisotopes; Receptors, Cell Surface; Time Factors; Tissue Distribution; Transplantation, Heterologous; Tumor Burden; Yttrium Radioisotopes

2009
A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy.
    Nuclear medicine and biology, 2010, Volume: 37, Issue:5

    Topics: Animals; Chelating Agents; Cross-Linking Reagents; Female; Heterocyclic Compounds, 1-Ring; Lutetium; Mice; Neoplasms; Porphyrins; Radioisotopes; Radionuclide Imaging; Treatment Outcome

2010
Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:2

    Topics: Animals; Biotransformation; Cell Line, Tumor; Cell-Penetrating Peptides; Female; Humans; Iodine Radioisotopes; Isotope Labeling; Lutetium; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2011
Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors.
    Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:3

    Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Chelating Agents; Chromatography, High Pressure Liquid; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Immunoconjugates; Isothiocyanates; Lutetium; Mice; Neoplasm Transplantation; Neoplasms; Radioimmunotherapy; Radioisotopes; Rats; Rats, Wistar; Time Factors

2011
Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12

    Topics: Amino Acid Sequence; Autoradiography; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Lutetium; Neoplasms; Oligopeptides; Protein Binding; Radioisotopes; Receptors, Somatostatin

2011
Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:12

    Topics: Animals; Female; HEK293 Cells; Humans; Indium Radioisotopes; Lutetium; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Octreotide; Organometallic Compounds; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Tissue Distribution

2012
[TREATMENT WITH RADIOISOTOPES].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1963, Volume: 54

    Topics: Ascites; Chromium Isotopes; Gold Isotopes; Heart Failure; Humans; Hydrothorax; Hyperthyroidism; Iodine Isotopes; Iridium; Lutetium; Myocardial Infarction; Neoplasms; Phosphorus Isotopes; Radioisotopes; Radiotherapy; Tantalum; Thyroid Neoplasms; Yttrium Isotopes

1963
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
    Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:4

    Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Cell Adhesion Molecules; Duodenum; Female; Femur; Humans; Iodine Radioisotopes; Kidney; Lectins; Liver; Lung; Lutetium; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Nude; Muscles; Neoplasm Transplantation; Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Sialic Acid Binding Ig-like Lectin 2; Spleen; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes

2003
Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:12

    Topics: Dose-Response Relationship, Drug; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lutetium; Male; Middle Aged; Neoplasms; Quality Control; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Silicates; Tomography, Emission-Computed; Whole-Body Counting

2003
186Re and high-specific-activity 177Lu available in North America.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:4

    Topics: Animals; Humans; Lutetium; Neoplasms; North America; Radioisotopes; Radiopharmaceuticals; Rhenium

2004
Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:5

    Topics: Body Weight; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Neoplasms; Posture; Prospective Studies; Radiopharmaceuticals; Silicates; Time Factors; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Tomography, X-Ray Computed

2004
Source of impaired image quality in 3D whole-body FDG PET scanning.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:8

    Topics: Artifacts; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Quality Control; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Silicates; Whole-Body Counting

2004
Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia.
    Bioorganic & medicinal chemistry, 2004, Dec-01, Volume: 12, Issue:23

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Fibrosarcoma; Hypoxia; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triazoles

2004
A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
    Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:1

    Topics: Actinium; Alpha Particles; Apoptosis; Beta Particles; Bismuth; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Enzyme-Linked Immunosorbent Assay; Humans; Ligands; Lutetium; Mitosis; Models, Statistical; Neoplasms; Octreotide; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin

2005
In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-15, Volume: 11, Issue:14

    Topics: Animals; Copper Radioisotopes; Humans; Immunoconjugates; Immunoglobulin Fragments; Lutetium; Mice; Mice, Nude; Neoplasms; Neural Cell Adhesion Molecule L1; Neuroblastoma; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured

2005
Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:1

    Topics: Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lutetium; Male; Medical Oncology; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Silicates; Whole Body Imaging

2006
[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Aged; Female; Humans; Indium Radioisotopes; Lutetium; Male; Middle Aged; Neoplasms; Octreotide; Organometallic Compounds; Radiation Dosage; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin

2001